Loading...
Sign in to edit your profile (add interests, mentoring, photo, etc.)

    Jing Cui, DSc, DABR

    TitleAssistant Professor of Clinical Radiation Oncology
    SchoolKeck School of Medicine of USC
    DepartmentRadiation Oncology
    AddressGNH 1100 N. State Street
    Health Sciences Campus
    Los Angeles California 90033
    Phone+1 323 409 1383
    vCardDownload vCard

      Collapse Bibliographic 
      Collapse Publications
      Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
      List All   |   Timeline
      1. Zou HY, Li Q, Lee JH, Arango ME, Burgess K, Qiu M, Engstrom LD, Yamazaki S, Parker M, Timofeevski S, Cui J, McTigue M, Los G, Bender SL, Smeal T, Christensen JG. Sensitivity of selected human tumor models to PF-04217903, a novel selective c-Met kinase inhibitor. Mol Cancer Ther. 2012 Apr; 11(4):1036-47. PMID: 22389468.
        View in: PubMed
      2. Zou HY, Li Q, Lee JH, Arango ME, McDonnell SR, Yamazaki S, Koudriakova TB, Alton G, Cui J, Kung PP, Nambu MD, Los G, Bender SL, Mroczkowski B, Christensen JG. An orally available small-molecule inhibitor of c-Met, PF-2341066, exhibits cytoreductive antitumor efficacy through antiproliferative and antiangiogenic mechanisms. Cancer Res. 2007 May 1; 67(9):4408-17. PMID: 17483355.
        View in: PubMed
      3. Agrawal RN, He S, Spee C, Cui J, Ryan SJ, Hinton DR. In vivo models of proliferative vitreoretinopathy. Nat Protoc. 2007; 2(1):67-77. PMID: 17401340.
        View in: PubMed
      4. Christensen JG, Schreck R, Burrows J, Kuruganti P, Chan E, Le P, Chen J, Wang X, Ruslim L, Blake R, Lipson KE, Ramphal J, Do S, Cui J, Cherrington JM, Mendel DB. A selective small molecule inhibitor of c-Met kinase inhibits c-Met-dependent phenotypes in vitro and exhibits cytoreductive antitumor activity in vivo. Cancer Res. 2003 Nov 1; 63(21):7345-55. PMID: 14612533.
        View in: PubMed
      5. Li X, Huang P, Cui J, Zhang J, Tang C. Novel pyrrolyllactone and pyrrolyllactam indolinones as potent cyclin-dependent kinase 2 inhibitors. Bioorg Med Chem Lett. 2003 Jun 2; 13(11):1939-42. PMID: 12749903.
        View in: PubMed
      6. Sun F, Cui J, Gavras H, Schwartz F. A novel class of tests for the detection of mitochondrial DNA-mutation involvement in diseases. Am J Hum Genet. 2003 Jun; 72(6):1515-26. PMID: 12730827.
        View in: PubMed
      7. Cui J, Araldi GL, Reiner JE, Reddy KM, Kemp SJ, Ho JZ, Siev DV, Mamedova L, Gibson TS, Gaudette JA, Minami NK, Anderson SM, Bradbury AE, Nolan TG, Semple JE. Non-covalent thrombin inhibitors featuring P3-heterocycles with P1-bicyclic arginine surrogates. Bioorg Med Chem Lett. 2002 Oct 21; 12(20):2925-30. PMID: 12270176.
        View in: PubMed
      8. Reiner JE, Siev DV, Araldi GL, Cui J, Ho JZ, Reddy KM, Mamedova L, Vu PH, Lee KS, Minami NK, Gibson TS, Anderson SM, Bradbury AE, Nolan TG, Semple JE. Non-covalent thrombin inhibitors featuring P(3)-heterocycles with P(1)-monocyclic arginine surrogates. Bioorg Med Chem Lett. 2002 Apr 22; 12(8):1203-8. PMID: 11934589.
        View in: PubMed
      Jing's Networks
      Concepts
      Derived automatically from this person's publications.
      _
      Co-Authors
      People in Profiles who have published with this person.
      _
      Similar People
      People who share similar concepts with this person.
      _
      Same Department